Copyright Reports & Markets. All rights reserved.

Global Mesalazine Enteric Coated Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Mesalazine Enteric Coated Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 0.25g
    • 1.3.3 0.5g
    • 1.3.4 1g
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Mesalazine Enteric Coated Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Mesalazine Enteric Coated Tablets Market Size & Forecast
    • 1.5.1 Global Mesalazine Enteric Coated Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Mesalazine Enteric Coated Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Mesalazine Enteric Coated Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Dr. Falk Pharma GmbH
    • 2.1.1 Dr. Falk Pharma GmbH Details
    • 2.1.2 Dr. Falk Pharma GmbH Major Business
    • 2.1.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product and Services
    • 2.1.4 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Dr. Falk Pharma GmbH Recent Developments/Updates
  • 2.2 Astellas Pharma Inc.
    • 2.2.1 Astellas Pharma Inc. Details
    • 2.2.2 Astellas Pharma Inc. Major Business
    • 2.2.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product and Services
    • 2.2.4 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Astellas Pharma Inc. Recent Developments/Updates
  • 2.3 AbbVie Inc.
    • 2.3.1 AbbVie Inc. Details
    • 2.3.2 AbbVie Inc. Major Business
    • 2.3.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Product and Services
    • 2.3.4 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AbbVie Inc. Recent Developments/Updates
  • 2.4 DSM Pharmaceuticals
    • 2.4.1 DSM Pharmaceuticals Details
    • 2.4.2 DSM Pharmaceuticals Major Business
    • 2.4.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product and Services
    • 2.4.4 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 DSM Pharmaceuticals Recent Developments/Updates
  • 2.5 Sun Pharmaceutical Industries Ltd.
    • 2.5.1 Sun Pharmaceutical Industries Ltd. Details
    • 2.5.2 Sun Pharmaceutical Industries Ltd. Major Business
    • 2.5.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product and Services
    • 2.5.4 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.6 Fosun Pharma
    • 2.6.1 Fosun Pharma Details
    • 2.6.2 Fosun Pharma Major Business
    • 2.6.3 Fosun Pharma Mesalazine Enteric Coated Tablets Product and Services
    • 2.6.4 Fosun Pharma Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Fosun Pharma Recent Developments/Updates
  • 2.7 Huahai Pharmaceuticals
    • 2.7.1 Huahai Pharmaceuticals Details
    • 2.7.2 Huahai Pharmaceuticals Major Business
    • 2.7.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product and Services
    • 2.7.4 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Huahai Pharmaceuticals Recent Developments/Updates
  • 2.8 UCB Pharma
    • 2.8.1 UCB Pharma Details
    • 2.8.2 UCB Pharma Major Business
    • 2.8.3 UCB Pharma Mesalazine Enteric Coated Tablets Product and Services
    • 2.8.4 UCB Pharma Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 UCB Pharma Recent Developments/Updates
  • 2.9 CR Sanjiu
    • 2.9.1 CR Sanjiu Details
    • 2.9.2 CR Sanjiu Major Business
    • 2.9.3 CR Sanjiu Mesalazine Enteric Coated Tablets Product and Services
    • 2.9.4 CR Sanjiu Mesalazine Enteric Coated Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CR Sanjiu Recent Developments/Updates

3 Competitive Environment: Mesalazine Enteric Coated Tablets by Manufacturer

  • 3.1 Global Mesalazine Enteric Coated Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Mesalazine Enteric Coated Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Mesalazine Enteric Coated Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Mesalazine Enteric Coated Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Mesalazine Enteric Coated Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Mesalazine Enteric Coated Tablets Manufacturer Market Share in 2025
  • 3.5 Mesalazine Enteric Coated Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Mesalazine Enteric Coated Tablets Market: Region Footprint
    • 3.5.2 Mesalazine Enteric Coated Tablets Market: Company Product Type Footprint
    • 3.5.3 Mesalazine Enteric Coated Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Mesalazine Enteric Coated Tablets Market Size by Region
    • 4.1.1 Global Mesalazine Enteric Coated Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Mesalazine Enteric Coated Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Mesalazine Enteric Coated Tablets Average Price by Region (2021-2032)
  • 4.2 North America Mesalazine Enteric Coated Tablets Consumption Value (2021-2032)
  • 4.3 Europe Mesalazine Enteric Coated Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Mesalazine Enteric Coated Tablets Consumption Value (2021-2032)
  • 4.5 South America Mesalazine Enteric Coated Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Mesalazine Enteric Coated Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Mesalazine Enteric Coated Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Mesalazine Enteric Coated Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Mesalazine Enteric Coated Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Mesalazine Enteric Coated Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Mesalazine Enteric Coated Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Mesalazine Enteric Coated Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Mesalazine Enteric Coated Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Mesalazine Enteric Coated Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Mesalazine Enteric Coated Tablets Market Size by Country
    • 7.3.1 North America Mesalazine Enteric Coated Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Mesalazine Enteric Coated Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Mesalazine Enteric Coated Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Mesalazine Enteric Coated Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Mesalazine Enteric Coated Tablets Market Size by Country
    • 8.3.1 Europe Mesalazine Enteric Coated Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Mesalazine Enteric Coated Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Mesalazine Enteric Coated Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Mesalazine Enteric Coated Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Mesalazine Enteric Coated Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Mesalazine Enteric Coated Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Mesalazine Enteric Coated Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Mesalazine Enteric Coated Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Mesalazine Enteric Coated Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Mesalazine Enteric Coated Tablets Market Size by Country
    • 10.3.1 South America Mesalazine Enteric Coated Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Mesalazine Enteric Coated Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Mesalazine Enteric Coated Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Mesalazine Enteric Coated Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Mesalazine Enteric Coated Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Mesalazine Enteric Coated Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Mesalazine Enteric Coated Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Mesalazine Enteric Coated Tablets Market Drivers
  • 12.2 Mesalazine Enteric Coated Tablets Market Restraints
  • 12.3 Mesalazine Enteric Coated Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Mesalazine Enteric Coated Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Mesalazine Enteric Coated Tablets
  • 13.3 Mesalazine Enteric Coated Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Mesalazine Enteric Coated Tablets Typical Distributors
  • 14.3 Mesalazine Enteric Coated Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Mesalazine Enteric Coated Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Mesalazine Enteric Coated Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Mesalazine Enteric Coated Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Mesalazine Enteric Coated Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Mesalazine Enteric Coated Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Mesalazine Enteric Coated Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Mesalazine Enteric Coated Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Mesalazine Enteric Coated Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Falk Pharma GmbH, Astellas Pharma Inc., AbbVie Inc., DSM Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Fosun Pharma, Huahai Pharmaceuticals, UCB Pharma, CR Sanjiu, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Mesalazine Enteric Coated Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    0.25g
    0.5g
    1g
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Dr. Falk Pharma GmbH
    Astellas Pharma Inc.
    AbbVie Inc.
    DSM Pharmaceuticals
    Sun Pharmaceutical Industries Ltd.
    Fosun Pharma
    Huahai Pharmaceuticals
    UCB Pharma
    CR Sanjiu
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Mesalazine Enteric Coated Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Mesalazine Enteric Coated Tablets, with price, sales quantity, revenue, and global market share of Mesalazine Enteric Coated Tablets from 2021 to 2026.
    Chapter 3, the Mesalazine Enteric Coated Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Mesalazine Enteric Coated Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mesalazine Enteric Coated Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Mesalazine Enteric Coated Tablets.
    Chapter 14 and 15, to describe Mesalazine Enteric Coated Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now